These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8265691)

  • 1. Reduction of spontaneous alcohol drinking and physical withdrawal by levemopamil, a novel Ca2+ channel antagonist, in rats.
    Rezvani AH; Pucilowski O; Grady DR; Janowsky D; O'Brien RA
    Pharmacol Biochem Behav; 1993 Oct; 46(2):365-71. PubMed ID: 8265691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oedema reduction by levemopamil in focal cerebral ischaemia of spontaneously hypertensive rats studied by magnetic resonance imaging.
    Elger B; Seega J; Raschack M
    Eur J Pharmacol; 1994 Mar; 254(1-2):65-71. PubMed ID: 8206118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levemopamil injection after cerebral oligemia reduces spatial memory deficits in rats.
    Heim C; Sieklucka M; Sontag KH
    Pharmacol Biochem Behav; 1994 Jul; 48(3):613-9. PubMed ID: 7938114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of alcohol consumption by MDMA (ecstasy) in two strains of alcohol-preferring rats.
    Rezvani AH; Garges PL; Miller DB; Gordon CJ
    Pharmacol Biochem Behav; 1992 Sep; 43(1):103-10. PubMed ID: 1357675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined therapy with dizocilpine and levemopamil does not reduce ischemic neuronal injury in rats.
    Sano T; Patel PM; Drummond JC; Cole DJ
    J Neurosurg Anesthesiol; 1993 Jul; 5(3):194-201. PubMed ID: 8400759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of alcohol consumption by fenfluramine in Fawn-Hooded rats with serotonin dysfunction.
    Rezvani AH; Grady DR
    Pharmacol Biochem Behav; 1994 May; 48(1):105-10. PubMed ID: 8029280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of alcohol and saccharin preference in rats by a novel Ca2+ channel inhibitor, Goe 5438.
    Pucilowski O; Rezvani AH; Janowsky DS
    Psychopharmacology (Berl); 1992; 107(2-3):447-52. PubMed ID: 1615142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging study on the effect of levemopamil on the size of intracerebral hemorrhage in rats.
    Elger B; Seega J; Brendel R
    Stroke; 1994 Sep; 25(9):1836-41. PubMed ID: 8073466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kudzu root extract suppresses voluntary alcohol intake and alcohol withdrawal symptoms in P rats receiving free access to water and alcohol.
    Benlhabib E; Baker JI; Keyler DE; Singh AK
    J Med Food; 2004; 7(2):168-79. PubMed ID: 15298764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased alcohol consumption by verapamil in alcohol preferring rats.
    Rezvani AH; Janowsky DS
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(4):623-31. PubMed ID: 2236588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ability of baclofen in reducing alcohol intake and withdrawal severity: I--Preclinical evidence.
    Colombo G; Agabio R; Carai MA; Lobina C; Pani M; Reali R; Addolorato G; Gessa GL
    Alcohol Clin Exp Res; 2000 Jan; 24(1):58-66. PubMed ID: 10656194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion- and T2-weighted imaging: evaluation of oedema reduction in focal cerebral ischaemia by the calcium and serotonin antagonist levemopamil.
    Seega J; Elger B
    Magn Reson Imaging; 1993; 11(3):401-9. PubMed ID: 8505874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of verapamil, an antagonist of L-type calcium channels, on cardiovascular symptoms in alcohol withdrawal.
    Kähkönen S; Bondarenko BB; Lipsanen J; Zvartau EE
    Neuropsychobiology; 2008; 58(3-4):123-7. PubMed ID: 18997479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel uncompetitive N-methyl-D-aspartate (NMDA)-receptor antagonist MRZ 2/579 suppresses ethanol intake in long-term ethanol-experienced rats and generalizes to ethanol cue in drug discrimination procedure.
    Hölter SM; Danysz W; Spanagel R
    J Pharmacol Exp Ther; 2000 Feb; 292(2):545-52. PubMed ID: 10640291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in alcohol consumption, withdrawal seizures, and monoamine transmission in rats treated with phentermine and 5-hydroxy-L-tryptophan.
    Halladay AK; Wagner GC; Sekowski A; Rothman RB; Baumann MH; Fisher H
    Synapse; 2006 Apr; 59(5):277-89. PubMed ID: 16416445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acamprosate and alcohol: II. Effects on alcohol withdrawal in the rat.
    Spanagel R; Putzke J; Stefferl A; Schöbitz B; Zieglgänsberger W
    Eur J Pharmacol; 1996 Jun; 305(1-3):45-50. PubMed ID: 8813530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute and chronic administration of delta 9-tetrahy-drocannabinol or cocaine on ethanol intake in a rat model.
    McMillan DE; Snodgrass SH
    Drug Alcohol Depend; 1991 May; 27(3):263-74. PubMed ID: 1653131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nimodipine and other calcium channel antagonists in alcohol-preferring AA rats.
    De Beun R; Schneider R; Klein A; Lohmann A; De Vry J
    Alcohol; 1996; 13(3):263-71. PubMed ID: 8734841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium entry and 5-HT2 receptor blockade in oliguric ischaemic acute renal failure: effects of levemopamil in conscious rats.
    Kramer HJ; Rosberg J; Bäcker A; Meyer-Lehnert H
    Br J Pharmacol; 1996 Mar; 117(6):1348-54. PubMed ID: 8882635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P rats develop physical dependence on alcohol via voluntary drinking: changes in seizure thresholds, anxiety, and patterns of alcohol drinking.
    Kampov-Polevoy AB; Matthews DB; Gause L; Morrow AL; Overstreet DH
    Alcohol Clin Exp Res; 2000 Mar; 24(3):278-84. PubMed ID: 10776663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.